首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Integrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living mice
【2h】

Integrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living mice

机译:通过活体小鼠近红外比率FRET成像定量分析血流和肿瘤中脂质纳米载体的完整性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lipid nanocarriers are considered as promising candidates for drug delivery and cancer targeting because of their low toxicity, biodegradability and capacity to encapsulate drugs and/or contrasting agents. However, their biomedical applications are currently limited because of a poor understanding of their integrity in vivo. To address this problem, we report on fluorescent nano-emulsion droplets of 100 nm size encapsulating lipophilic near-infrared cyanine 5.5 and 7.5 dyes with a help of bulky hydrophobic counterion tetraphenylborate. Excellent brightness and efficient Förster Resonance Energy Transfer (FRET) inside lipid NCs enabled for the first time quantitative fluorescence ratiometric imaging of NCs integrity directly in the blood circulation, liver and tumor xenografts of living mice using a whole-animal imaging set-up. This unique methodology revealed that the integrity of our FRET NCs in the blood circulation of healthy mice is preserved at 93% at 6 h of post-administration, while it drops to 66% in the liver (half-life is 8.2 h). Moreover, these NCs show fast and efficient accumulation in tumors, where they enter in nearly intact form (77% integrity at 2 h) before losing their integrity to 40% at 6 h (half-life is 4.4 h). Thus, we propose a simple and robust methodology based on ratiometric FRET imaging in vivo to evaluate quantitatively nanocarrier integrity in small animals. We also demonstrate that nano-emulsion droplets are remarkably stable nano-objects that remain nearly intact in the blood circulation and release their content mainly after entering tumors.
机译:脂质纳米载体因其低毒性,可生物降解性和包封药物和/或造影剂的能力而被认为是药物输送和癌症靶向的有前途的候选者。但是,由于对它们在体内的完整性了解甚少,它们的生物医学应用目前受到限制。为了解决这个问题,我们报告了在体积大的疏水抗衡离子四苯基硼酸酯的帮助下,封装了亲脂性近红外花青5.5和7.5染料的100 nm尺寸的荧光纳米乳剂液滴。脂质NC内部具有出色的亮度和有效的Förster共振能量转移(FRET)功能,这使得首次使用全动物成像设置直接在活体小鼠的血液循环,肝脏和肿瘤异种移植物中对NC完整性进行定量荧光比例成像。这种独特的方法表明,在给药后6小时,健康小鼠血液循环中我们FRET NC的完整性保持在93%,而在肝脏中则降至66%(半衰期为8.2小时)。而且,这些NC在肿瘤中显示出快速有效的积累,它们以几乎完整的形式进入(2小时时77%的完整性),然后在6小时时其完整性降至40%的半衰期(半衰期为4.4小时)。因此,我们提出了一种基于比率FRET体内成像的简单而强大的方法,以定量评估小动物中纳米载体的完整性。我们还证明,纳米乳液液滴是非常稳定的纳米物体,在血液循环中几乎保持完好无损,并且主要在进入肿瘤后释放其含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号